Funding the Cell & Gene Therapy Boom
The ascent of cell and gene therapies (CGT) is commonly regarded as one of the momentous turning points in the history of the pharmaceuticals…
Tagged with Funding
John-Arne Røttingen – CEO, The Research Council of Norway
John-Arne Røttingen, CEO of The Research Council of Norway shares his career journey from academia to industry, outlines his new role as Norway's…
Anne Kjersti Fahlvik – Executive Director, Industries,…
Anne Kjersti Fahlvik of the Research Council of Norway highlights the health sector’s increasing importance to the Nordic nation, the country’s…
China Pharma News Roundup August 2020
A roundup of the latest news from Chinese pharma, including Big Pharma players losing out in the latest round of domestic procurement bidding, updates…
Company Spotlight: I-Mab Biopharma
The only company in our Summer 2020 edition of InFocus: 5 Biotechs to Watch in China to be helmed by a non-founding CEO, I-Mab Biopharma has advanced…
Hong Kong Biotech IPOs since Listing Reform in April 2018
On 30 April 2018, Hong Kong Stock Exchange’s (HKEX’s) introduced a number of reforms to allow and support the listing of pre-profit biotech…
Joan Shen – CEO, I-Mab Biopharma
Dr Joan Shen, CEO of I-Mab Biopharma, shares her impressive career journey across companies like Pfizer, Janssen and Jiangsu Hengrui, before joining…
Jielun Zhu – CFO, I-Mab Biopharma, China
I-Mab Biopharma CFO Jielun Zhu recaps the exciting milestones for the company over the past year since our last interview in May 2019, including most…
Michael Zhang – Chairman, Peijia Medical, China
Michael Zhang, chairman of Peijia Medical, shares Peijia Medical’s mission to become a two-platform medical device company as well as the partner of…
A Pharma Funding Overview & Outlook for 2020
Michael Jewell, partner and head of healthcare & life sciences at Cavendish Corporate Finance looks back at the key trends across pharma industry…
Yuzo Toda – Chairman, Forum for Innovative Regenerative…
Yuzo Toda, chairman of the Forum for Innovative Regenerative Medicine (FIRM) in Japan, discusses how the organization acts as a translational bridge…
Makoto Suematsu – President, Japan Agency for Medical…
Makoto Suematsu, president of the Japan Agency for Medical Research and Development (AMED), discusses AMED’s successful unification of Japan’s…
